Mustang Bio MBIO
NASDAQ MBIO
$0.44 -0.01 (-2.24%)
As of: Nov 11, 2026 · 2:59 PM EST

Mustang Bio (MBIO) Long-Term Debt Repayments (2016 - 2017)

Updated

Mustang Bio's Long-Term Debt Repayments came in at $30.38 million for FY2023.

Analysis

Mustang Bio (MBIO) Long-Term Debt Repayments (2016 - 2017) Analysis & Trends

Going back to FY2016, Mustang Bio's Long-Term Debt Repayments data covers 4 years.

  • Long-Term Debt Repayments carries a three-year compound annual growth rate of 24.5% (FY2020 to FY2023).
  • The FY2023 figure represents the lowest annual Long-Term Debt Repayments since FY2020.
  • Per Business Quant, earlier years put Long-Term Debt Repayments at $15.75 million in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Repayment (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 1.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -4.91 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 3.05 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 19.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Mustang Bio 3.03 Mn -60.03 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2017 320,000.00
Dec 31, 2016 -1.53 Mn
Sep 30, 2016 3.53 Mn
API Access

Mustang Bio Long-Term Debt Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=MBIO&period=max&api_key=YOUR_API_KEY